Received Sep 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Shingrix vaccine gave me GBS, which has disabled me for approximately one year; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Shingrix vaccine gave me GBS, which has disabled me for approximately one year) (serious criteria disability and GSK medically significant). The outcome of the guillain barre syndrome was not reported. The reporter considered the guillain barre syndrome to be possibly related to Shingrix. The company considered the guillain barre syndrome to be unrelated to Shingrix. Additional Information: GSK receipt date: 24-AUG-2025 This case was reported by a patient via interactive digital media. The patient reported that Shingrix vaccine gave her GBS (Guillain Barre syndrome), which had disabled her for approximately one year. She had a questioned how could had advertised product and not been part of the vaccine GBS (Guillain Barre syndrome) fund.; Sender's Comments: A case of Guillain-Barre syndrome, an unknown time after receiving Shingrix, in a adult female patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.